Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABACUS: Preoperative Atezolizumab in Bladder Cancer
NCT02662309Phase 2Completed
- Sponsor
- Queen Mary University of London
- Start
- Feb 2016
- Primary completion
- Jun 2020
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of atezolizumab in bladder cancer, sponsored by Queen Mary University of London. Started Feb 2016; status: completed.
02
Drugs
atezolizumab
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT02662309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02662309.